Dernière minute
FR«La pire attaque depuis le début de la guerre en Ukraine» : ce que l’on sait des frappes russes sur Kiev, qui ont fait au moins 30 mortsFRAffaire Jubillar : Cédric Jubillar reconnaît sa culpabilité dans la disparition de son épouseFRDes scientifiques et personnalités réclament une "loi d'urgence climatique"FRLa France se prépare au retour de la caniculeFRTour de France: Third stage to Les Angles without public due to wildfireFRLa Chine effectue un tir d'essai de missile dans le PacifiqueFRPFAS : une dépollution coûteuse et inefficace pour l'EuropeFREspagne-Portugal : les duels qui décideront du choc des huitièmes de finale du MondialFRBanijay Group rachète les 33 casinos Joa pour 430 millions d'eurosCRYPTO-FRSolana prend du terrain sur Ethereum dans la tokenisation des actifs du monde réel (RWA)FR«La pire attaque depuis le début de la guerre en Ukraine» : ce que l’on sait des frappes russes sur Kiev, qui ont fait au moins 30 mortsFRAffaire Jubillar : Cédric Jubillar reconnaît sa culpabilité dans la disparition de son épouseFRDes scientifiques et personnalités réclament une "loi d'urgence climatique"FRLa France se prépare au retour de la caniculeFRTour de France: Third stage to Les Angles without public due to wildfireFRLa Chine effectue un tir d'essai de missile dans le PacifiqueFRPFAS : une dépollution coûteuse et inefficace pour l'EuropeFREspagne-Portugal : les duels qui décideront du choc des huitièmes de finale du MondialFRBanijay Group rachète les 33 casinos Joa pour 430 millions d'eurosCRYPTO-FRSolana prend du terrain sur Ethereum dans la tokenisation des actifs du monde réel (RWA)
Newsgather
BackSK hynix Resubmits F-1 Form with SEC, Cites Litigation Risks
SK hynix Resubmits F-1 Form with SEC, Cites Litigation Risks
En développement
Yonhap News5 g önceBusiness1 dk okumaSouth Korea

SK hynix Resubmits F-1 Form with SEC, Cites Litigation Risks

L'essentiel

  • SK hynix has resubmitted an amended F-1 Form to the SEC, disclosing potential litigation risks from an antitrust class action suit over DRAM pricing.
  • The company also reported a leading 56.4% market share in HBM in Q1.

Résumé généré par IA

Pourquoi c'est important

SK hynix is seeking to list on the U.S. market and has filed an amended F-1 registration with the SEC. The company is a major player in the memory semiconductor market.

Taille de police

SEOUL, July 1 (Yonhap) -- SK hynix Inc. has resubmitted an amended F-1 Form registration with the U.S. Securities Exchange Commission (SEC) this week, which included potential litigation risks, as it proceeds with its bid to list on the U.S. market.

According to the filing submitted Tuesday (local time), SK hynix said a "putative antitrust class action suit" was filed in the U.S. District Court for the Northern District of California on Thursday (local time), brought by "indirect purchasers of conventional DRAM products."

The plaintiffs alleged SK hynix, its U.S. subsidiary and two other memory semiconductor makers "conspired to restrict the supply of and inflate prices for conventional DRAM beginning in approximately October 2022," the document read.

Also in the filing, the South Korean chip giant said it has ranked first in the global High Bandwidth Memory (HBM) market, with 56.4 percent market share in the first quarter. It was also the second-largest supplier of NAND flash memory based on revenue during the period, citing data from IDC, a global market intelligence firm.

SK hynix said it plans to use the proceeds to pay for the construction of production facilities in South Korea, as well as its acquisition of EUV scanners, expected to cost around 11.9 trillion won (US$7.6 billion), and to be delivered by December of 2027.

The company did not state any details of the ADSs, including its offering price, as it did in its previous filing submitted last Wednesday.

Such details will be determined through negotiations with underwriters, and will be based on the last reported trading price of common shares, as well as prevailing market conditions and other factors, the chipmaker added.

Questions ouvertes

  • What will be the outcome of the antitrust lawsuit?
  • What will be the offering price for the U.S. listing?
  • How will the litigation impact the IPO valuation?

Sujets liés

This article was originally published by Yonhap News.

Articles liés

대구시, AI 기반 의료기기 제조 기반 구축 사업 선정…국비 60억 확보
En développement·11 dk önce

대구시, AI 기반 의료기기 제조 기반 구축 사업 선정…국비 60억 확보

대구시가 산업통상부 공모 사업에 선정되어 인공지능(AI) 제조공정 기반 인체 이식용 섬유융합 의료기기 제조 기반 구축을 위해 국비 60억 원을 확보했다. 이 사업은 2030년까지 총 100억 원을 투입하여 의료용 필라멘트 원사 생산 기반을 구축하고 고부가가치 의료기기 국산화와 공급망 안정화를 목표로 한다.

연합뉴스
Plus sur ce sujetSK hynix